Navigation Links
Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
Date:12/10/2007

Company Selected to Participate in Gastroenterology Panel Discussion

ISELIN, N.J., Dec. 10 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) announced today that Chief Executive Officer Elkan R. Gamzu, Ph.D. will participate in a gastroenterology-focused panel discussion at the 2007 RBC Capital Markets Healthcare Conference taking place December 12 - 13, 2007 at the Westin New York at Times Square in New York, New York. The panel is entitled "Going With Your Gut: New Treatments for GI Disorders," and is scheduled to commence at 8:00 AM Eastern Time on Wednesday, December 12, 2007.

An audio-only webcast and replay of Pharmos' presentation will be available at http://www.wsw.com/webcast/rbc84/panel1 and can be accessed via the Company's website at http://www.pharmoscorp.com.

Pharmos Corporation is a biopharmaceutical company that discovers and develops novel therapeutics to treat a range of diseases of the nervous system, including disorders of the brain-gut axis, with a focus on pain/inflammation and autoimmune disorders. The Company's lead product, dextofisopam, is being studied in a Phase 2b clinical trial in patients with irritable bowel syndrome (IBS). Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033) and was very well tolerated. A second clinical program currently in Phase 2a testing is Pharmos' proprietary NanoEmulsion cream drug delivery system formulated with the NSAID diclofenac, which is being studied as a treatm
'/>"/>

SOURCE Pharmos Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. Pharmos Corporation Reports 2007 Third Quarter Results
3. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
4. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
5. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
6. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
7. BioElectronics Corporation Announces Singapore and Malaysia Sales
8. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
9. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
10. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
11. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Nov. 27 Cromoz Inc., located in Re...carbon nanotube-based cancer drug delivery system ...tubes, which have functional groups on the walls t...developed in partnership with the Indian Institute...serves as a drug delivery vehicle with the ability...
(Date:11/25/2009)...5 Biotech firm Replikins Ltd., whi...the 1918 pandemic through the prediction, outbreak... issued its latest biochemical analysis of the vir...1N1 ("Swine Flu") virus has dropped from its peak ...eak in the spring of 2009 to resting non-epidemic ...
(Date:11/25/2009)... 25 Reportlinker.com announces tha... catalogue: ,, Brazil Bioethanol Market Analys...linker.com/p0165503/Brazil-Bioethanol-Market-Analy...hanol Market Analysis and Forecasts to 2013 ,, ...sis and forecasts of the global bioethanol market ...
(Date:11/24/2009)...w York investment bank KTA Capital,s client Neuren...7 mil convertible note private placement with a U....as arranged by KTA Capital as Neuren,s exclusive p... New York (PRWEB) November 23, 2009 -- The ind... ("KTA Capital") has announced that its ...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...ram to Launch at the Annual Oncology Nursing Socie... Amgen (Nasdaq: AMGN ) and ONS Edge , a subsidi...nnounced that they will partner alongside celebrit...upport a new educational campaign, Coping with Ca... at educating oncology nurses about the skin-relat...
...ceuticals, Inc., a privately held drug development...sented on its novel molecule, AFP-464, during the ..."This research represents a significant advancemen...r, one of the most aggressive forms of invasive br...resident and Chief Executive Officer of Tigris. ...
...rtible debentures of Victhom , to be completed by ...PRNewswire-FirstCall/ - Victhom Human Bionics Inc....bH ("Otto Bock") announced today the execution on ...lish a joint venture to develop and commercialize ...urobionix division. , The objective of this joint ...
Other Biology Technology:Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 4Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 5Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 6Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5
(Date:11/30/2009)...ilable in German . , The DFG has approved t...Centres as of 1 January 2010. This decision was ma...nn. The new centres will initially be funded for f..., 20 percent overhead funding for indirect costs w..., research topics range from modern prostheses to ...
(Date:11/30/2009)...Journal of Experimental Biology are pleased to an...de la Recherche Scientifique (CNRS) in the Univers...year,s JEB Outstanding Paper Prize. ,The prize i...ment and is intended to encourage young scientists... and adds that ,we truly appreciate when authors s...
(Date:11/30/2009)...es continue to rise scientists are presented with ... respond and adapt. In a paper published in Insec...uez-Trelles and Dr Miguel Rodriguez assess this ch...pproximately 0.6˚C has already affected the E...ologists and evolutionary biologists is to predict...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4How can scientists measure evolutionary responses to climate change? 2REPEL CV 28TM 29 Adhesion Barrier Receives Endorsement of Kids With Heart 13453 1REPEL CV 28TM 29 Adhesion Barrier Receives Endorsement of Kids With Heart 13453 2Slide Into Debt Could Bring Wider Waistline 53941 1Slide Into Debt Could Bring Wider Waistline 53941 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4
...on for the development of allergy may be malfuncti...ergens to bind to, enter and travel through the ep...n this subject have recently been published in two...and (2) Journal of Allergy and Clinical Immunolog...focused on the understanding of aberrant immunores...
...le, MA -- Three leading research centers based in ...f the Woods Hole Consortium, a new alliance that w...on some of the major issues facing society today a...the South Coast of Massachusetts. , The consortiu...atory (MBL), Woods Hole Oceanographic Institution ...
...Ind. A new study in the The Journal of Applied P...y their workouts to avoid extensive muscle loss du...ion (ISS). , The latest NASA-sponsored research f...ratory (HPL) suggests that changes are needed to o...ts to improve their muscle performance while in sp...
Other Biology News:Malfunction of the respiratory epithelium is a cause of allergy? 23 Woods Hole scientific institutions forge alliance to address societal issues 23 Woods Hole scientific institutions forge alliance to address societal issues 3Astronauts may need more intense workouts to maintain muscle fitness in space 2
...Microdissection (LCM) is the method of choice for ...issection is the only instrument to offer both LCM...y., UV Laser Cutting provides unprecedente...es and capturing large numbers of cells. , LCM ...
Hybridizer (220 V) from Dako
...00 System is an automated multiplexing platform th...ing SNP detection, pathogen sequence detection and...ith multiple targets can be applied to an open and...ridge, which may be reused until all tests sites h...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: